<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Keller, Dan</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Bilous, Rudolf</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Candesartan Fails to Prevent Microalbuminuria in Hypertensive Diabetics When Stringent Criteria are Used</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2010</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2010-11-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">27-28</style></pages><abstract><style  face="normal" font="default" size="100%">This article presents a reanalysis of the three DIRECT with the aim of investigating whether candesartan reduced incident microalbuminuria in normotensive (blood pressure &lt;130/85 mm Hg) and well-controlled hypertensive type 2 diabetes mellitus patients, using the less stringent definition of microalbuminuria of a single value &gt;20 μg/min.</style></abstract><number><style face="normal" font="default" size="100%">9</style></number><volume><style face="normal" font="default" size="100%">10</style></volume></record></records></xml>